Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESTO-2: Short-course Antibiotic Therapy for Children With Community-acquired Pneumonia
NCT06125340Phase 4Recruiting
- Start
- Apr 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin in community acquired pneumonia (CAP). Started Apr 2024; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT06125340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125340.